Adamas Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch ADMS and buy or sell other stocks, ETFs, and their options commission-free!

About ADMS

Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia.

CEO

Neil F. McFarlane

CEONeil F. McFarlane

Employees

—

Employees—

Headquarters

Emeryville, California

HeadquartersEmeryville, California

Founded

2000

Founded2000

Employees

—

Employees—

ADMS Key Statistics

Market cap

376.37M

Market cap376.37M

Price-Earnings ratio

-4.85

Price-Earnings ratio-4.85

Dividend yield

—

Dividend yield—

Average volume

964.73K

Average volume964.73K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$9.15

52 Week high$9.15

52 Week low

$4.02

52 Week low$4.02